首页> 外国专利> Molecular markers derived from bombesina radioactive for diagnosis and therapy of tumors superexpressam receptors for peptu00ecdeo releasing gastrina and their application.

Molecular markers derived from bombesina radioactive for diagnosis and therapy of tumors superexpressam receptors for peptu00ecdeo releasing gastrina and their application.

机译:放射性轰击分子衍生的分子标记物,用于肿瘤超表达受体的诊断和治疗,用于释放胃t的肽及其应用。

摘要

Molecular markers derived from bombesina radioactive for diagnosis and therapy of tumors superexpressam receptors for peptideo releasing gastrina and its applications the present invention refers to a series of radiolabelled compounds for diagnosis and treatment of tumors that And superexpressam receptors for the peptide releasing gastrina, such as tumors of the prostate.Breast and lung, among others, and their metastases. The compounds are analogues of the bombesina, a neuropeptideo derived from anfibio of 14 amino acids, and have been proposed after studies of molecular modeling, by which the original structure of the bombesina was modified in its first five amino acids.The molecular markers resulting from the unprecedented changes have provided good results in studies of radiolabelling and stability in vitro and have the main advantage compared to the fast whitening sangtiu00edneo existing markers, the low accumulation of abdominal and seletivi Dade by tumour cells in vivo.Demonstrated in preclinical studies involving mice animal model of human healthy and tumor.
机译:衍生自用于诊断和治疗肿瘤的超表达素受体的用于放射的多肽的分子标记及其在应用中的用途本发明涉及用于诊断和治疗肿瘤的一系列放射性标记的化合物以及用于表达释放胶体的肽的超表达受体,例如肿瘤前列腺,乳腺和肺及其转移。这些化合物是轰击类似物的一种类似物,它是一种由14个氨基酸的抗生物素衍生的神经肽,是在分子模型研究后提出的,通过这种方法,轰击蛋白的原始结构在其前五个氨基酸中得到了修饰。前所未有的变化在体外放射标记和稳定性研究中提供了良好的结果,并且与快速美白的现有标记物,体内肿瘤细胞对腹部和选择性Dade的低积累相比具有主要优势。在涉及临床前研究中证明小鼠人类健康和肿瘤动物模型。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号